Delivering Innovative Products to the Canadian Market
Medexus Pharma Canada is a Canadian-based specialty pharmaceutical company focused on the key areas of rheumatology, auto-immune disease, pediatrics, allergy, and dermatology. The company manages the licensing, registration, marketing, sales, and distribution of several innovative pharmaceutical products in Canada.
Medexus Pharma Canada leverages its extensive market knowledge and strong Canadian position as an innovator with new and existing products to deliver clinically proven safe and effective brands and consistent product value.
As part of its commitment to continued growth in current and new therapeutic areas, the company fosters many unique relationships with customers and healthcare professionals, as well as with key partners around the globe.
Pediapharm, a division of Medexus Pharma Canada, distributes and licenses innovative prescription medicines used to treat pathological conditions that primarily affect the pediatric community.
By partnering with leading healthcare entities around the world, Pediapharm continues to bring innovative products to the Canadian market and improve the health and the well-being of the Canadian children and adult population.
These products may not be right for you. Always read and follow the label.
The contents of this site are for informational purposes only and are not intended, nor should they be used, as a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician, pharmacist or other qualified health care provider with any questions you may have regarding a medical condition and/or the use of these products. Also read the product monograph and/or the consumer information provided with the product.
About Medexus
Medexus Pharmaceuticals Inc. is a leading innovative and rare disease pharmaceutical company with a focus on the therapeutic areas of rheumatology, auto-immune disease, specialty oncology, allergy, and pediatric diseases.